Salvianolic acid A derivative-1 (Compound SAA-30) is an orally active derivative of Salvianolic acid A. It binds to transgelin with a KD of 2.39 µM and enhances cell contraction by promoting actin aggregation. This compound may be used for the prevention of myocardial ischemia or other diseases associated with ischemia-reperfusion (IR) tissue injury.
Target-Kategorie:
Arp2/3 Complex
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
